FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness. The FDA is ordering drugmakers to add a new warning labels on GLP-1 injectables and...
Gizmodo FDA Orders New Vision Loss Warning for Ozempic and Other GLP-1s
Health regulators have found a consistent link between GLP-1 use and the eye condition NAION.
Lean: Leans left Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: G/O Media
The Hill FDA warns of rare ‘eye stroke’ risk from GLP-1 drugs
The Food and Drug Administration (FDA) on Monday required pharmaceutical companies to warn patients and healthcare providers of a potential increased risk of a serious eye condition associated with the use of GLP-1...
Lean: Center Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: Nexstar Media Group
ABC News (US) FDA adds rare vision-loss warning to popular GLP-1 drugs
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic
Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: Walt Disney Company
New York Post GLP-1 drugs must have new warning label over incurable blindness condition, says FDA
You're going to want to keep an eye on this.
Lean: Right Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: News Corp
.jpeg?width=1200&auto=webp&crop=3%3A2)
